Sigachi MENA FZCO, a wholly owned subsidiary of Sigachi Industries Limited, has signed a Memorandum of Understanding (MoU) with Respilon, an innovation-driven nanofiber R&D company headquartered in the Czech Republic. This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.

The MoU was signed between Lijo Chacko, Managing Director of Sigachi MENA FZCO, and Roman Zima, Chief Business Officer of Respilon Group s.r.o, during a formal ceremony on April 24, 2025.

Commenting on this development, Amit Raj Sinha, Managing Director and CEO of Sigachi Industries, said: "Partnering with Respilon aligns perfectly with our vision to deliver next-generation pharmaceutical solutions that improve therapeutic outcomes and elevate the patient experience. We are excited about the possibilities NUENEX® technology offers to revolutionize drug delivery systems globally."

Commenting on this development,  Zima, Chief Business Officer of Respilon Group s.r.o stated "We are delighted to partner with Sigachi, whose deep industry expertise and global reach will accelerate the deployment of NUENEX® across pharmaceutical markets. Together, we aspire to redefine drug delivery with safer, more effective, and sustainable solutions for patients worldwide."